Galecto Stock (NASDAQ: GLTO) stock price, news, charts, stock research, profile.
Open | $0.700 |
Close | $0.671 |
Volume / Avg. | 75.622K / 223.317K |
Day Range | 0.650 - 0.710 |
52 Wk Range | 0.500 - 3.700 |
Market Cap | $18.979M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Galecto (NASDAQ: GLTO) through any online brokerage.
Other companies in Galecto’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Galecto (NASDAQ: GLTO) was reported by HC Wainwright & Co. on Thursday, September 28, 2023. The analyst firm set a price target for 0.00 expecting GLTO to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
The stock price for Galecto (NASDAQ: GLTO) is $0.7 last updated April 24, 2024 at 4:18 PM EDT.
There are no upcoming dividends for Galecto.
Galecto’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Galecto.
Galecto is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.